文献速递胃肠外科围术期管理与 ERAS

优化减重手术:全国15年研究降低并发症并改善康复

Refining Bariatric Surgery: A Nationwide 15-year Study to Reduce Morbidity and Improve Recovery.
PubMed 文献 · Ann Surg · 2025-08-06

该研究基于法国国家健康数据库,回顾性分析2009至2023年间486161例首次减重手术,评估术后死亡率和并发症的演变。结果显示90天死亡率0.1%,随时间下降40%,再手术率从4.9%降至4.5%,重症监护入住率下降58%,但袖状胃切除术和胃旁路术后2018年起改善停滞。

要点

  • 减重手术90天死亡率为0.1%,可调节胃束带术最低。
  • 死亡率15年间下降40%,但袖状胃切除和胃旁路术自2018年趋于平台。
  • 再手术率由4.9%降至4.5%,严重并发症ICU入住率下降58%。

核心结论

  • 减重手术安全性随时间提升,死亡率和并发症率下降,但近年改善停滞,需进一步优化策略。

研究设计与样本

  • 回顾性队列研究,利用法国国家健康数据库(SNDS)纳入2009至2023年18至65岁以肥胖为主要诊断的首次减重手术患者,共486161例。

主要发现

  • 总体90天死亡率为0.1%,不同术式间差异显著(P < 0.001),可调节胃束带术死亡率最低。
  • 死亡率随时间下降40%,但袖状胃切除术和胃旁路术自2018年起呈现平台效应。
  • 再手术率从4.9%降至4.5%,严重并发症(Clavien-Dindo IV)的ICU入住率下降58%。
  • 术后药物使用变化:镇痛药减少29.4%,抗抑郁药减少15.7%,抗焦虑药减少12.7%,泻药增加86.4%。

临床怎么用

  • 减重手术应继续作为多模式肥胖治疗的一部分,并关注近年安全改善停滞的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the evolution of postoperative mortality and morbidity associated with bariatric surgery over a 15-year period using a nationwide database. BACKGROUND: Bariatric surgery is a cornerstone in obesity management, demonstrating significant benefits in weight loss and comorbidity resolution. However, despite its proven efficacy, it remains underutilized, with only a small fraction of eligible patients undergoing surgery. Advances in surgical techniques and perioperative care have improved safety, yet long-term trends in mortality and morbidity require further evaluation. METHODS: This retrospective cohort study utilized data from the SNDS (Système National des Données de Santé), France's national health care database, covering all bariatric procedures performed between 2009 and 2023. Patients aged 18 to 65 years with a primary diagnosis of obesity were included. Outcomes assessed included 90-day and 180-day mortality, severe complications (Clavien-Dindo IV), reoperations, hospital readmissions, and postoperative medication use. RESULTS: Among 486,161 first-time bariatric procedures, sleeve gastrectomy and gastric bypass dominated. The overall 90-day mortality rate was 0.1%, varying significantly by procedure ( P < 0.001), with adjustable gastric banding exhibiting the lowest rate. Mortality decreased by 40% over time, but sleeve gastrectomy and gastric bypass showed a plateau effect since 2018. Reoperations declined (4.9%-4.5%), and intensive care unit admissions for severe complications fell by 58%. Medication analysis revealed reduced analgesic (-29.4%), antidepressant (-15.7%), and anxiolytic (-12.7%) use, while laxative consumption increased (+86.4%). CONCLUSIONS: Bariatric surgery has become safer over time, with declining mortality and complication rates. However, the stagnation of improvements in recent years highlights the need for further optimization strategies. These findings support the continued integration of surgery within a multimodal obesity treatment paradigm.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Muller O, Marciniak C, Lenne X, et al. Refining Bariatric Surgery: A Nationwide 15-year Study to Reduce Morbidity and Improve Recovery. Ann Surg. 2025. PMID: 40767567. doi:10.1097/SLA.0000000000006881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。